Low-molecular-weight heparin for thrombophilia in pregnant women

International Journal of Gynecology and Obstetrics

Volumn 69, Issue 3, 2000, Pages 209-213

  Bar, J ^a   Cohen Sacher, B ^a   Hod, M ^a   Blickstein, D ^a   Lahav, J ^a   Merlob, P ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Aspirin; Low molecular weight heparin; Pregnancy; Safety; Thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; CLEXAN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; UNCLASSIFIED DRUG;

ABORTION; ARTICLE; CLINICAL ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FETUS DEATH; FIRST TRIMESTER PREGNANCY; HUMAN; INCIDENCE; INTRAUTERINE GROWTH RETARDATION; PATENT DUCTUS ARTERIOSUS; POLYDACTYLY; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RECURRENT ABORTION; SECOND TRIMESTER PREGNANCY; TERATOGENESIS; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 0034213883     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(00)00202-2     Document Type: Article

References (20)

1. Collins R., Serimgeour A., Yusuf S., Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general orthopedic and urologic surgery. N Engl J Med. 318:1988;1162-1173.
2. Flessa H.C., Kapstrom A.B., Glueck H.I., Will J.J. Placental transport of heparin. Am J Obstet Gynecol. 93:1954;570-573.
3. Shefras J., Farquharson R.G. Bone density studies in pregnant women receiving heparin. Eur J Obstet Gynecol Reprod Biol. 65:1996;171-174.
4. Warkentin T.E., Levine M.N., Hirsh J. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 332:1995;1330-1335.
5. Bara L., Samama M. Pharmacokinetics of low molecular weight heparins. Acta Chir Scand Suppl. 543:1988;65-72.
6. Dulitzki M., Pauzner R., Langevitz P. Low molecular weight heparin during pregnancy and delivery preliminary experience with 41 pregnancies. Obstet Gynecol. 878:1996;380-383.
7. Omri A., Delaloye J.F., Anderson H., Bachmann F. Low molecular weight heparin Novo LHN-1 does not cross the placenta during the second trimester of pregnancy. Thromb Haemost. 61:1989;55-56.
8. Melissari E., Parker C.J., Kakkar V.V. Use of low dose molecular weight heparin in pregnancy. Thromb Haemostasis. 62:1989;451-453.
9. Andrew M., Ofasu F., Fernanxez A. A low molecular weight heparin alters the fetal coagulation system in the pregnant sheep. Thromb Haemostasis. 55:1986;342-346.
10. Saivin S., Giroux M., Dumas J.C., Faure F., Rekik L., Grandjean H. et al. Placental transfer of glycosaminoglycans in the human perfused placental cotyledon model. Eur J Obstet Gynecol Reprod Biol. 42:1991;22-225.
11. Haywood L., Brown M.D. Antiphospholipid antibodies and recurrent pregnancy loss. Clin Obstet Gynecol. 34:1991;1-17.
12. Preston F.E., Rosendaal F.R., Walker I.D. Increased fetal loss in women with heritable thrombophilia. Lancet. 348:1966;913-916.
13. Kupferminc M.J., Eldor A., Steinman N. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 340:1999;9-13.
14. Harris E.N. The second international anticardiolipin standardization workshop/the Kingston Antiphospholipid Antibody Study (KAPS) group. Am J Clin Pathol. 94:1990;476-484.
15. Dekker J.A., de Vries J.I.P., Doelitzsch P.M. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol. 173:1994;1042-1048.
16. de Vries J.I.P., Dekker G.A., Huijgens P.C. Hyperhomocysteinemia and protein S deficiency in complicated pregnancies. Br J Obstet Gynaecol. 104:1997;1248-1254.
17. Daly L., McLeady B., Graham I. Fasting or post-methionine load homocysteine which should be measured in relation to vascular risk? Irish J Med Sci. 164:1995;6.
18. Rai R., Cohen H., Dave M., Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies or antiphospholipid antibodies. Br Med J. 314:1997;253-257.
19. Sanson B.J., Lensing A.W.A., Prins M.H. Safety of low-molecular-weight heparin in pregnancy: a systemic review. Thromb Haemostasis. 81:1999;1-5.
20. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low dose aspirin alone. Am J Obstet Gynecol. 174:1996;1584-1589.